Roberto Borea: Study on NSCLC Metastatic Recurrence Prediction Selected for WCLC 2026
Roberto Borea/LinkedIn

Roberto Borea: Study on NSCLC Metastatic Recurrence Prediction Selected for WCLC 2026

Roberto Borea, Assistant Prof at The Ohio State University, shared on X:

“Our work on whole-transcriptome profiling for metastatic recurrence prediction in early-stage NSCLC will be presented as an oral presentation at WCLC2026 in Seoul. Grateful to Christian Rolfo for his mentorship in advancing precision oncology.

Roberto Borea

Session M011: Innovative Approaches to Lung Cancer Biomarker Discovery.

Tue, Sep 15 | 11:07 AM KST

Room 102, Grand Ballroom

Special thanks to Giovanni Nigita and Diego Enrico for their invaluable contributions to this project!”

You might be interested in:

Adjuvant Crizotinib Fails in Resected ALK-Positive NSCLC: What E4512 Tells Us About Targeted Therapy in Early Disease

Roberto Borea: Study on NSCLC Metastatic Recurrence Prediction Selected for WCLC 2026